ABBA, I get the feeling as long as current management is in control, our Vegas party will have to wait. Many of them already have at the minimal of 180k options at 0.43 from last year. This runs to 4$ it's 720k worth. I don't think that's enough for them. Even at 8$ per share, it's only 1.44 million.
So I bet their plan was to hold out until this year end where they can award million more options on the NDA filing before a partnership or deal would be signed. SK does own far more shares and options but maybe the other directors and officers are asking for more?
If that's what they were planning, the share price or even going to OTC none of that matters. They just wanted more shares, get enough money to keep operating which do suggest they see future value in Cytrx but maybe next year instead.
Our chances of wining some is slim when it comes to such greedy management. At least RS isn't happening, so holding out at least have reduced risk short term.
Market Data 
Markets 
AI
